Corporeal Compression at the Onset of Septic shock (COCOONs): a compression method to reduce fluid balance of septic shock patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 08 2019
Historique:
received: 08 01 2019
accepted: 26 07 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 27 10 2020
Statut: epublish

Résumé

Fluid overload in septic intensive care unit (ICU) patients is common and strongly associated with poor outcome. There is currently no treatment for capillary leak, which is mainly responsible for high positive fluid balance (FB) in sepsis. We hypothesized that increasing interstitial pressure with extensive corporeal compression would reduce FB. The objective of this study was to evaluate the feasibility, efficacy, and safety of a compression treatment during sepsis. This pilot, two-center, single-arm trial enrolled critically ill, non-surgical, septic patients receiving mechanical ventilation. The therapeutic intervention was the early application of compression bandages on more than 80% of the body surface. The primary outcome was negative net FB on day 7. The primary endpoint was reached in 29 of 45 patients (64%) with available data, for a planned objective of 26. By day 4, cumulative FB was 7280 ml [3300-9700]. SOFA- and aged-matched patients from a historical cohort had a significantly higher FB at 1, 2 and 7 days. Tolerance was good, although low-stage pressure ulcers were observed in 16 patients (26%). No effect on intra-abdominal pressure or respiratory plateau pressure was observed. In conclusion, corporeal compression demonstrated potential efficacy in limiting FB during septic shock, with acceptable feasibility and tolerance.

Identifiants

pubmed: 31399609
doi: 10.1038/s41598-019-47939-2
pii: 10.1038/s41598-019-47939-2
pmc: PMC6689006
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

11566

Investigateurs

Maël Hamet (M)
Thomas Poussant (T)
Martial Delorme (M)
Adrien Lhoumeau (A)
Thierry Comte (T)
Abderrahmane Bourredjem (A)

Références

N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
Sci Transl Med. 2011 Jun 22;3(88):88ps25
pubmed: 21697528
Ann Am Thorac Soc. 2018 Feb;15(2):250-257
pubmed: 29388815
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Crit Care Med. 2011 Feb;39(2):259-65
pubmed: 20975548
N Engl J Med. 2018 Oct 11;379(15):1431-1442
pubmed: 30304656
Anesthesiology. 2007 May;106(5):944-51
pubmed: 17457125
Crit Care. 2008;12(3):R74
pubmed: 18533029
Intensive Care Med. 2014 Dec;40(12):1795-815
pubmed: 25392034
J Intensive Care Med. 2014 Jul-Aug;29(4):213-7
pubmed: 23753235
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Acta Clin Belg. 2007;62 Suppl 1:44-59
pubmed: 24881700
Dermatol Surg. 2000 Mar;26(3):244-7
pubmed: 10759802
Intensive Care Med. 2006 Nov;32(11):1722-32
pubmed: 16967294
Chest. 2000 Jun;117(6):1749-54
pubmed: 10858412
Phlebology. 2014 May 19;29(1 suppl):7-12
pubmed: 24843079
Control Clin Trials. 1989 Mar;10(1):1-10
pubmed: 2702835
Cardiovasc Res. 2010 Jul 15;87(2):198-210
pubmed: 20200043
Ann Intensive Care. 2017 Dec;7(1):2
pubmed: 28050895
N Engl J Med. 2010 Aug 12;363(7):689-91
pubmed: 20818861
Crit Care Clin. 2018 Jan;34(1):43-61
pubmed: 29149941
Acta Anaesthesiol Scand. 2003 Feb;47(2):111-21
pubmed: 12631039
Adv Skin Wound Care. 2007 May;20(5):269-74
pubmed: 17473563
Int Angiol. 2010 Oct;29(5):426-30
pubmed: 20924346
Clin J Am Soc Nephrol. 2011 May;6(5):966-73
pubmed: 21393482
Intensive Care Med. 1998 Jan;24(1):18-27
pubmed: 9503218
Ann Intensive Care. 2012 Jul 05;2(Suppl 1 Diagnosis and management of intra-abdominal hyperten):S1
pubmed: 22873410

Auteurs

Auguste Dargent (A)

Department of intensive care, François Mitterrand University Hospital, Dijon, France. auguste.dargent@chu-dijon.fr.
INSERM Research Center UMR 1231 and LabEx LipSTIC, Lipness Team, University of Burgundy, Dijon, France. auguste.dargent@chu-dijon.fr.

Audrey Large (A)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.

Agnès Soudry-Faure (A)

CHU Dijon Bourgogne, Clinical Research Unit-Methodological Support Network, Dijon, France.

Jean-Marc Doise (JM)

Department of intensive care, William Morey Hospital, Chalon-sur-Saône, France.

Caroline Abdulmalak (C)

Department of intensive care, William Morey Hospital, Chalon-sur-Saône, France.

Lysiane Jonval (L)

CHU Dijon Bourgogne, Clinical Research Unit-Methodological Support Network, Dijon, France.

Pascal Andreu (P)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.

Jean-Baptiste Roudaut (JB)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.

Sébastien Prin (S)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.

Pierre-Emmanuel Charles (PE)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.
INSERM Research Center UMR 1231 and LabEx LipSTIC, Lipness Team, University of Burgundy, Dijon, France.

Didier Payen (D)

UMR 1160 INSERM, Paris 7 University, AP-HP, Paris, France.

Jean-Pierre Quenot (JP)

Department of intensive care, François Mitterrand University Hospital, Dijon, France.
INSERM Research Center UMR 1231 and LabEx LipSTIC, Lipness Team, University of Burgundy, Dijon, France.
INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH